Pending Acquisition of NuRay (NuRay [Member])

3 Months Ended

Mar. 31, 2014

NuRay [Member]

Business Acquisition [Line Items]

Business Acquisition Disclosure

Pending Acquisition of Nuray Assets:

On November 1, 2013, our wholly-owned subsidiary, Par Formulations Private Limited, entered into a definitive agreement to purchase certain assets of privately-held Nuray Chemicals Private Limited ("Nuray"), a Chennai, India based developer and manufacturer of active pharmaceutical ingredients (“API”) for up to $19 million in cash and contingent payments. The assets to be acquired consist of Nuray’s API business located in Kakkalur, Tamil Nadu, India, including real property, improvements and related assets (the “Kakkalur Business”). The closing of the acquisition is subject to the receipt of applicable regulatory approvals and other customary closing terms and conditions. The acquisition will be accounted for as a business combination under the guidance of ASC 805. The operating results of the Kakkalur Business will be included in our consolidated financial results from the date of the closing of the acquisition as part of the Par Pharmaceutical segment. We will fund the purchase from cash on hand.